Multifunctional Drug also may help with Alzheimer’s

News from the web:

University Feinberg School of Medicine have developed a new “one-size-fits-all” therapy drug that could potentially treat Alzheimer’s, Parkinson’s disease, multiple sclerosis and traumatic brain injury

The drug’s trick lies in reducing a particular type of inflammation in the brain known as neuroinflammation.  This brain response has become increasingly considered a common denominator for many neurological disorders, as well as playing a major role in brain injuries.  To decrease inflammation, the drug developed at Northwestern binds to and decreases a molecule known as cytokine, which is released in large quantities during the neuroinflammatory response.
Read all about it HERE

visit us at AlzheimerHeadlines.com

Major setback in Alzheimer Drug quest

News from the web:

Pfizer said Monday that a highly anticipated experimental drug for Alzheimer’s disease, called bapineuzumab, wasn’t effective at slowing memory loss in a large, late-stage clinical trial in patients with a high-risk genetic mutation.

The negative result from this trial, the first of two late-stage trials on bapineuzumab to be announced this year, was expected by many scientists and investors, but it is nonetheless a disappointment to the companies and for the field of Alzheimer’s research.

Read all about it HERE

visit us at AlzheimerHeadlines.com

Food for Alzheimer’s

News from the web:

Nestle has bought a stake in U.S. firm Accera to support the rollout of a medical food brand for Alzheimer’s patients, as the world’s biggest food group seeks to expand in the health and nutrition business
Nestle said Axona provides an alternative energy source for Alzheimer’s patients, whose brains become less able to use glucose, resulting in improved memory and cognitive function, according to ongoing clinical trials.

Read all about it HERE

visit us at AlzheimerHeadlines.com

Two Proteins that cause Alzheimer’s

News from the web:

Still relatively little is known about exactly what makes Alzheimer’s disease destroy the brain. Now scientists have at least agreed that two proteins, that long have had separate research groups looking at them,  together are a major cause of Alzheimer’s and that our best bet to fight off Alzheimer’s may well be to prevent both proteins from developing their harmful works.

Read all about it HERE

visit us at AlzheimerHeadlines.com

Can coconut oil help Alzheimer’s? disease?

News from the web:

There are several theories on how coconut oil might work in Alzheimer’s disease, but nothing has been proven. Unfortunately, too, the studies have included very few patients: 23 in one six-week study and 20 in another. One article that I reviewed on the use of coconut oil could find no peer-reviewed clinical studies on its use in AD. The company that manufactures Axona studied 152 patients for 90 days. Although the company claimed benefit, at 90 days both those who were taking coconut oil, and those who were not, had similar testing scores.

Read all about it HERE

visit us at AlzheimerHeadlines.com

Don’t wait for the magic bullet

News from the web:

Alvaro Fernandez reviews the current state of research and the prevalence of biomedical solutions to Alzheimer. He continues to make the case for life long Mental Health instead of relying on “magic bullet” drugs or treatments.

Alvaro is the co-author of he SharpBrains Guide to Brain Fitness: http://www.sharpbrains.com/book/

Read all about it HERE

visit us at AlzheimerHeadlines.com